

Please try another search
Zealand Pharma A/S (NASDAQ:ZEAL) announced that it has initiated the second phase III study to evaluate its pipeline candidate, dasiglucagon, in pediatric patients with congenital hyperinsulinism...
As of late, it has definitely been a great time to be an investor Zealand Pharma A/S (NASDAQ:ZEAL) . The stock has moved higher by 2.9% in the past month, while it is also above its 20 Day SMA too....
The biotech sector saw updates from a few bigwigs last week. Both Regeneron (NASDAQ:REGN) and Biogen (NASDAQ:BIIB) obtained positive opinions on their drugs from the CHMP. Meanwhile, Amgen...
This week, a number of companies are set to launch the initial public offering of their shares. These companies include Zealand Pharma (NASDAQ:ZEAL), Contura Energy (NYSE:CTRA) and Ranger Energy...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review